<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00969475</url>
  </required_header>
  <id_info>
    <org_study_id>MF-01</org_study_id>
    <nct_id>NCT00969475</nct_id>
  </id_info>
  <brief_title>The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure</brief_title>
  <official_title>The Effects of Fractional CO2 Resurfacing Prior to Complex Wound Closure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moy-Fincher Medical Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moy-Fincher Medical Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if fractional carbon dioxide laser treatment of a
      fresh wound at the time of surgery, decreases scar formation. Scar revision is commonly done
      at 6-10 weeks following surgery. Therefore, it may be more beneficial, for both the patient
      and physician, to perform scar revision at the time of surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of scar improvement as assessed by blinded-observer and patient ratings.</measure>
    <time_frame>At two and six weeks following the procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Scars</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Half of each subject's wound will not be treated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laser resurfacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Half of each subject's wound will be treated with a fractional CO2 laser.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lumenis fractional carbon dioxide laser</intervention_name>
    <description>intra-operative laser resurfacing at time of wound closure</description>
    <arm_group_label>Laser resurfacing</arm_group_label>
    <other_name>Lumenis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing skin cancer surgery

          -  Will have a straight-line incision

          -  Fluent in English

          -  Must reside in the Los Angeles vicinity for the duration of the study

        Exclusion Criteria:

          -  Non-English speakers

          -  Pregnant or cognitively impaired subjects
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Ozog, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moy-Fincher Medical Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Telia DeBoyes</last_name>
    <email>tdeboyes@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moy-Fincher Medical Group</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>310-794-7422</phone>
    </contact>
    <investigator>
      <last_name>David Ozog, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edgar Fincher, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ronald Moy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisa Chipps, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2009</study_first_submitted>
  <study_first_submitted_qc>August 31, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2009</study_first_posted>
  <last_update_submitted>September 13, 2009</last_update_submitted>
  <last_update_submitted_qc>September 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ronald Moy, MD</name_title>
    <organization>Moy-Fincher Medical Group</organization>
  </responsible_party>
  <keyword>scar revision</keyword>
  <keyword>intraoperative</keyword>
  <keyword>fractional carbon dioxide laser</keyword>
  <pending_results>
    <submitted>July 24, 2011</submitted>
    <returned>August 18, 2011</returned>
    <submitted>August 20, 2011</submitted>
    <returned>September 26, 2011</returned>
    <submitted>April 19, 2012</submitted>
    <returned>May 16, 2012</returned>
    <submitted>May 18, 2012</submitted>
    <returned>June 20, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

